| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | May 19, 2025 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -15,995 | -9.05% | ✗ | $14.1K |
| Mar 5, 2025 | Mar 7, 2025 | SUTRO BIOPHARMA, INC. | CFO | Sell | 47.5 | -3,594 | -2.65% | ✗ | $4.9K |
| Mar 4, 2025 | Mar 6, 2025 | SUTRO BIOPHARMA, INC. | CFO | Sell | 47.5 | -3,748 | -2.87% | ✗ | $5.3K |
| Mar 1, 2025 | Mar 4, 2025 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -10,320 | -7.83% | ✗ | $16.4K |
| Mar 5, 2024 | Mar 7, 2024 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -3,100 | -2.82% | ✗ | $14.1K |
| Mar 4, 2024 | Mar 6, 2024 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -3,472 | -3.32% | ✗ | $16.6K |
| Mar 1, 2024 | Mar 5, 2024 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -3,227 | -3.27% | ✗ | $16K |
| Jan 29, 2024 | Jan 31, 2024 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -2,151 | -2.31% | ✗ | $10.7K |
| Mar 3, 2023 | Mar 7, 2023 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -6,588 | -6.99% | ✗ | $38.1K |
| Jan 27, 2023 | Jan 31, 2023 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -2,140 | -6.51% | ✗ | $16.1K |
| Mar 5, 2022 | Mar 7, 2022 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -3,145 | -10.23% | ✗ | $25.7K |
| Jan 29, 2022 | Feb 1, 2022 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -2,151 | -8.91% | ✗ | $22.3K |
| Sep 24, 2021 | Sep 28, 2021 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -2,480 | -11.60% | ✗ | $47.7K |
| Jan 29, 2021 | Feb 1, 2021 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -2,126 | -13.02% | ✗ | $47.1K |
| Sep 25, 2020 | Sep 28, 2020 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -2,480 | -18.29% | ✗ | $25.5K |
| Sep 26, 2019 | Sep 30, 2019 | SUTRO BIOPHARMA, INC. | CFO | Sell | 46.3 | -2,480 | -27.98% | ✗ | $24.2K |